Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
Bionano Genomics announced the publication of a large peer-reviewed study showing that their Optical Genome Mapping (OGM) technology detected genomic abnormalities in 97.8% of T-ALL cases, nearly doubling the detection rate of traditional karyotyping (55%). The study highlights OGM’s ability to uncover complex genetic changes in this aggressive leu…